SoDu-Based Chimerix Acquired in $935M Deal
The agreement, expected to close later this year, brings Chimerix’s promising brain cancer drug, dordaviprone, into Jazz’s growing oncology portfolio.
The agreement, expected to close later this year, brings Chimerix’s promising brain cancer drug, dordaviprone, into Jazz’s growing oncology portfolio.
A daily, hyper-local word/phrase challenge pulled from recent Southpoint Access coverage.
District 3 representative Jessica Carda-Auten won't seek re-election in March 2026. Plus, catch up on Thursday's Durham City Council work session.
A daily, hyper-local word/phrase challenge pulled from recent Southpoint Access coverage.
When tradition meets counterprogramming - and a kid becomes Rambo with Legos.